Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues      
Total revenues $ 189,698 $ 209,023 $ 112,408
Cost of sales      
Total cost of sales 199,788 193,952 94,115
Gross profit (loss) (10,090) 15,071 18,293
Operating expenses      
Research and development 85,096 96,878 68,131
Sales and marketing 40,334 68,091 47,995
General and administrative 66,272 83,065 78,041
In-process research and development assets acquired     25,581
Impairment charges 8,518    
Goodwill impairment 112,911 498,800  
Total operating expenses 313,131 746,834 219,748
Loss from operations (323,221) (731,763) (201,455)
Change in fair value of warrant liability     (56,576)
Interest expense (4,099) (1,743) (149)
Interest and other (expense) income, net 944 (8,335) (11,822)
Loss before income taxes (326,376) (741,841) (270,002)
Income tax benefit 3,105 1,498 29,668
Net loss $ (323,271) $ (740,343) $ (240,334)
Net loss per share-basic $ (1.00) $ (2.35) $ (0.92)
Net loss per share-diluted $ (1.00) $ (2.35) $ (0.92)
Weighted average shares outstanding, basic 322,196 314,817 260,770
Weighted average shares outstanding, diluted 322,196 314,817 260,770
Products      
Revenues      
Total revenues $ 168,091 $ 190,248 $ 105,994
Cost of sales      
Total cost of sales 184,614 178,952 87,450
Services      
Revenues      
Total revenues 21,607 18,775 6,414
Cost of sales      
Total cost of sales $ 15,174 $ 15,000 $ 6,665